샘플 요청 목록

 카트 문의
시장보고서
상품코드
1993855

GMP 바이오의약품 시장 : 제품 유형별, 용도별, 서비스별, 제조 규모별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2025-2032년)

GMP Biologics Market, By Product Type, By Application, By Service, By Manufacturing Scale, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 387 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

GMP 바이오의약품 시장 규모는 2024년에 678억 1,087만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 15.98%로 확대될 것으로 전망됩니다.

GMP 생물의약품은 일관된 품질, 안전성, 유효성을 보장하기 위해 국내외 규제 당국이 인정한 적정 제조 기준(GMP)을 준수하여 대량 생산되는 생물학적 제제를 말합니다. 바이오로직스는 생세포에서 유래한 복합 치료제로서 단클론항체, 백신, 재조합 단백질, 그리고 첨단 세포 및 유전자 치료제를 포함합니다. 구조적 취약성과 고도의 제조 공정으로 인해 원자재 조달에서 최종 포장에 이르기까지 모든 단계에서 엄격한 규제 감독이 요구됩니다.

세계 거버넌스 측면에서 세계보건기구(WHO)와 같은 기관은 의약품의 품질 기준을 조화시키기 위해 100개국 이상에서 채택된 국제적으로 인정받는 GMP 가이드라인을 제공하고 있습니다. 이와 함께 미국 식품의약국(FDA)과 유럽의약품청(EMA)을 포함한 규제 당국은 최근 몇 년 동안 생물학적 제제 및 바이오시밀러의 승인 건수가 꾸준히 증가하고 있으며, 이는 암, 자가면역질환 및 희귀질환에 대한 첨단 치료제의 역할이 확대되고 있음을 반영하고 있습니다. 역할을 확대하고 있음을 반영하고 있습니다. 공중보건 데이터에 따르면, 주요 시장에서 신규 승인된 치료제 중 생물학적 제제가 현재 큰 비중을 차지하고 있으며, 이는 고품질 바이오 제조 능력의 확대와 세계 의약품 공급망의 탄력성 확보에 대한 각국 정부의 높은 관심을 뒷받침하고 있습니다.

GMP 바이오의약품 시장 - 시장 역학

장기적인 헬스케어의 지속가능성을 뒷받침하는 첨단 생물학적 제제 요법에 대한 수요 증가

헬스케어 시스템에서는 치료 결과의 향상과 장기적인 치료 부담의 감소를 기대할 수 있어 만성질환 및 복합질환에 대한 표적형 생물학적 제제 치료가 점점 더 우선순위가 높아지고 있습니다. 이러한 정밀의료로의 전환은 고품질 GMP 인증 생산 인프라에 대한 수요를 가속화하여 시장의 꾸준한 확대에 기여하고 있습니다. 암, 자가면역질환 등 만성질환이 전 세계 질병부담을 점점 더 많이 차지하고 있는 가운데, 각국 정부는 장기입원 및 체계적 비용 절감을 위해 생물학적 제제를 우선순위에 두고 있습니다. 예를 들어, 인도 정부는 2026-27년 연방 예산에서 12억 달러의 예산을 투입하여 바이오의약품 및 바이오시밀러의 세계 제조 거점이 될 'Biopharma SHAKTI' 이니셔티브를 출범시켰습니다. 화이자와 일라이 릴리와 같은 대기업들도 이러한 수요에 대응하기 위해 GMP를 준수하는 생산 체제를 확대하고 있으며, 세계 바이오의약품 시장은 2026년까지 5,340억 달러가 넘을 것으로 예상됩니다. GMP 바이오의약품 부문은 표적 치료제의 확장 가능한 생산을 보장함으로써 강력하고 가치 중심의 세계 헬스케어 생태계에 필수적인 인프라를 제공하고 있습니다.

GMP 바이오의약품 시장 - 시장 세분화 분석:

세계 GMP 바이오의약품 시장은 제품 유형, 용도, 서비스, 제조 규모, 최종사용자 및 지역에 따라 세분화됩니다.

제품 유형에 따라 세계 시장은 단클론항체(mAbs), 재조합 단백질, 백신, 세포 및 유전자 치료제 등 4개 카테고리로 분류됩니다. 단클론항체는 가까운 미래에 세계 바이오의약품 시장에서 가장 중요한 역할을 할 분야로 널리 인식되고 있습니다. mAbs는 암, 자가면역질환 등 주요 만성 및 복합질환 치료에서 효과가 입증되었고, 기존 치료법에 비해 부작용이 적으며, 질병 경로를 정밀하게 표적화할 수 있어 이미 전 세계 바이오의약품 매출에서 가장 큰 비중을 차지하고 있습니다. 실제로 미국 식품의약국(FDA)은 최근 몇 년 동안 많은 단클론항체 치료제를 승인하고 있으며, 2024년에는 역대 최다 mAb 승인 건수를 기록하는 등 임상적 중요성이 높아지고 있습니다. 로슈, 애브비, 화이자 등 주요 바이오 제약사들은 견고한 단클론항체 포트폴리오를 구축하고 있으며, 세계 수요에 대응하기 위해 GMP를 준수하는 생산능력을 지속적으로 확장하고 있습니다. 허셉틴(로슈), 휴미라(애브비)와 같은 블록버스터 치료제가 지속적인 상업적 성과와 보급을 주도하고 있습니다.

시장은 제조 규모에 따라 임상 규모, 상업 규모, 파일럿 규모의 세 가지 범주로 나뉩니다. 상업적 규모의 제조는 GMP 바이오의약품 시장에서 전 세계적으로 괄목할 만한 성장을 기록할 것으로 예상됩니다. 이는 승인된 생물의약품 치료제가 임상 개발 단계를 통과한 후 대량으로 안정적으로 생산할 수 있도록 하기 위한 것으로, 단클론항체, 백신, 유전자 치료제 등의 치료법에 대한 전 세계 수요를 충족시키고 광범위한 환자 접근성을 지원하는 데 필수적이기 때문입니다. 삼성바이오로직스와 같이 수십만 리터가 넘는 대규모 GMP 공장을 여러 개 건설하고 있는 주요 제조 전문 기업들은 화이자와 같은 대형 제약 파트너사와의 장기 공급 계약에 대응하기 위해 상업적 생산 거점을 적극적으로 확장하고 있습니다. 동시에 미국 식품의약국(FDA)과 같은 규제 당국은 소규모 생산 및 임상 생산에서 본격적인 상업용 바이오의약품 공급으로 전환하는 과정에서 엄격한 GMP 기준과 승인 요건을 유지함으로써, 전 세계적으로 신뢰할 수 있는 고품질 바이오의약품을 확보하는 데 있어 상업적 제조 인프라의 핵심적인 역할을 더욱 강화하고 있습니다. 핵심적인 역할을 더욱 공고히 하고 있습니다.

GMP 바이오의약품 시장 - 지역별 인사이트

지리적 관점에서 볼 때, 북미는 선진적인 규제 인프라와 강력한 공중보건 투자에 힘입어 GMP 바이오의약품 제조 및 혁신의 중요한 거점이 될 것으로 예상됩니다. 미국 식품의약국(FDA)은 엄격한 우수의약품제조관리기준(GMP) 준수를 감독하여 고품질의 바이오의약품 생산을 보장하고, 수백 개의 바이오의약품을 치료 용도로 승인하고 있습니다. 미국은 국내의 광범위한 수요와 산업 역량을 반영하여 세계 최대 규모의 바이오의약품 제조 시설 집적지 중 하나이며, 단클론항체, 백신, 재조합 단백질에 대한 탄탄한 개발 파이프라인을 보유하고 있습니다. 캐나다도 지역의 강점에 기여하고 있으며, 국내 의약품 지출에서 바이오의약품이 차지하는 비중이 높아 헬스케어 시스템 내에서 바이오 치료제의 지속적인 통합이 진행되고 있음을 보여줍니다.

업계 관점에서 볼 때, 주요 제약사 및 생명공학 기업들은 국내 시장과 수출 시장 모두에 대응하기 위해 북미의 바이오의약품 생산능력을 확장하고 있습니다. Amgen과 Pfizer와 같은 미국 기반의 혁신적인 기업들은 대규모 GMP 준수 시설을 운영하며 차세대 바이오의약품 제조 기술에 지속적으로 투자하고 있습니다. 이들 기업은 생산 효율을 향상시키면서 진화하는 품질 기준을 준수하기 위해 연방 정부 기관과 긴밀하게 협력하고 있습니다. 캐나다의 경우, 국가 규제 지침은 국제 GMP 표준 준수를 장려하여 국경을 초월한 제약 활동을 장려하고 있습니다. 전반적으로 북미의 규제적 보장, 헬스케어 수요, 기업 투자가 세계 GMP 바이오의약품 시장에서 북미의 중요한 역할을 뒷받침하고 있습니다.

중국 GMP 바이오의약품 시장 - 국가별 인사이트

중국은 적극적인 정부 정책과 국내 산업 역량 향상에 힘입어 바이오의약품 제조에서 점점 더 중요한 역할을 하고 있습니다. 국가약품감독관리국은 2024년 말 바이오의약품의 단계별 생산에 대한 시범 프로그램을 도입했습니다. 이를 통해 바이오의약품 제조의 각 단계에 특화된 시설을 구축하여 효율성을 높이고 GMP 표준을 준수할 수 있습니다. WuXi Biologics와 국영기업인 China National Pharmaceutical Group Corporation과 같은 중국의 주요 기업들은 백신, 항체 의약품, 복합 치료용 단백질 등 중국의 바이오의약품 생산에 큰 기여를 하고 있습니다. 생산에 크게 기여하고 있습니다. 이러한 추세는 중국이 국내 헬스케어 수요를 충족하고 수출 기회를 확대하기 위해 제조 생태계 강화, 규제 일관성 제고, 혁신 지원에 전략적으로 집중하고 있음을 반영하고 있습니다.

목차

제1장 GMP 바이오의약품 시장 개요

제2장 주요 요약

제3장 GMP 바이오의약품 주요 시장 동향

제4장 GMP 바이오의약품 산업 분석

제5장 GMP 바이오의약품 시장 : 높아지는 지정학적 긴장의 영향

제6장 GMP 바이오의약품 시장 구도

제7장 GMP 바이오의약품 시장 : 제품 유형별

제8장 GMP 바이오의약품 시장 : 용도별

제9장 GMP 바이오의약품 시장 : 서비스별

제10장 GMP 바이오의약품 시장 : 제조 규모별

제11장 GMP 바이오의약품 시장 : 최종사용자별

제12장 GMP 바이오의약품 시장 : 지역별

제13장 주요 벤더 분석 : GMP 바이오의약품 산업

제14장 AnalystView 전방위 전망

KSM

GMP Biologics Market size was valued at US$ 67,810.87 Million in 2024, expanding at a CAGR of 15.98% from 2025 to 2032.

GMP Biologics refers to biological medicines that are mass-produced in compliance with Good Manufacturing Practice (GMP) standards recognized by national and international regulatory authorities to ensure consistent quality, safety, and effectiveness. Biologics are compound therapies derived from living cells and include monoclonal antibodies, vaccines, recombinant proteins, and advanced cell and gene therapies. Due to their structural sensitivity and sophisticated production processes, strict regulatory oversight is required at every stage from raw material sourcing to final packaging.

From a global governance view, institutions such as the World Health Organization provide internationally recognized GMP guidelines adopted by more than 100 countries to harmonize pharmaceutical quality standards. In parallel, regulatory authorities, including the U.S. Food and Drug Administration and the European Medicines Agency (EMA), have reported a consistent rise in biologics and biosimilar approvals over recent years, reflecting the growing role of advanced therapies in addressing cancer, autoimmune disorders, and rare diseases. Public health data further specify that biologic products now represent a significant share of newly approved therapeutic agents in major markets, underscoring strong governmental emphasis on expanding high-quality biomanufacturing capacity and ensuring resilient pharmaceutical supply chains worldwide.

GMP Biologics Market- Market Dynamics

Rising demand for advanced biologic therapies to support long-term healthcare sustainability

Healthcare systems are increasingly prioritizing targeted biologic treatments for chronic and complex diseases due to their potential to improve outcomes and reduce long-term treatment burden. This shift toward precision medicine is accelerating the need for high-quality GMP-certified production infrastructure, contributing to steady market expansion. As chronic conditions like cancer and autoimmune disorders increasingly dominate the global disease burden, governments are prioritizing biologics to reduce long-term hospitalizations and systemic costs. For instance, the Government of India, in its Union Budget 2026-27, launched the "Biopharma SHAKTI" initiative with an outlay of $1.2 billion to establish a global manufacturing hub for biologics and biosimilars. Similarly, corporate leaders like Pfizer and Eli Lilly are scaling GMP-compliant production to meet this need, with the global biologics market projected to exceed $534 billion by 2026. By ensuring the scalable production of targeted therapies, the GMP biologics sector provides the essential infrastructure for a resilient, value-based global healthcare ecosystem.

GMP Biologics Market- Segmentation Analysis:

The Global GMP Biologics Market is segmented on the basis of Product Type, Application, Service, Manufacturing Scale, End User, and Region.

On the basis of product type global market is divided into four categories: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, and Cell & Gene Therapies. Monoclonal Antibodies are widely acknowledged as the segment set to play the most pivotal role in the global biologics market in the near term. mAbs already account for the largest share of biologics revenue globally due to their proven effectiveness in treating major chronic and complex diseases such as cancer and autoimmune disorders, and their ability to target disease pathways with precision and fewer side effects than many traditional therapies. In fact, the U.S. Food and Drug Administration (FDA) approved a notably high number of monoclonal antibody therapies in recent years, including a record number of mAb approvals in 2024, reinforcing their clinical importance. Major biopharmaceutical players such as Roche, AbbVie, and Pfizer have built robust monoclonal antibody portfolios and continue to expand GMP-compliant production capacity to meet global demand, with blockbuster therapies like Herceptin (Roche) and Humira (AbbVie) driving sustained commercial performance and uptake.

The market is divided into three categories based on manufacturing scale: Clinical Scale, Commercial Scale, and Pilot Scale. Commercial-scale manufacturing is forecasted to register meaningful growth in the GMP biologics market at a global level because it enables the large volume, consistent production of approved biologic therapies once they clear clinical development, which is essential to meet worldwide demand for treatments such as monoclonal antibodies, vaccines, and gene-based therapies and to support broad patient access. Leading manufacturing specialists like Samsung Biologics, which has built multiple large capacity GMP plants exceeding hundreds of thousands of liters, are actively expanding their commercial production footprint to serve long term supply contracts with major pharmaceutical partners such as Pfizer and others. At the same time, regulators like the U.S. Food and Drug Administration (FDA) maintain stringent GMP expectations and approvals that underpin the transition from small-scale and clinical production to full-scale commercial biologics supply, reinforcing the central role of commercial manufacturing infrastructure in ensuring reliable, high-quality biologic availability worldwide.

GMP Biologics Market- Geographical Insights

From the geographical point of view shows that North America is expected to remains a influential hub for GMP biologics manufacturing and innovation, supported by advanced regulatory infrastructure and strong public health investment. In the United States, the U.S. Food and Drug Administration oversees stringent good manufacturing practice (GMP) compliance, ensuring high-quality biologics production, and has approved hundreds of biologic products for therapeutic use. The U.S. benefits from one of the largest concentrations of biologics manufacturing facilities and a robust pipeline of monoclonal antibodies, vaccines, and recombinant proteins, reflecting broad domestic demand and industry capability. Canada also contributes to regional strength, with biologics accounting for a significant share of national pharmaceutical expenditure, indicating sustained integration of biotherapeutic products within healthcare systems.

From an industry perception, leading pharmaceutical and biotech companies are expanding their biologics manufacturing capacity in North America to serve both domestic and export markets. U.S.-based innovators like Amgen and Pfizer operate large GMP-compliant facilities and continue to invest in next-generation biologic production technologies. These firms work closely with federal agencies to adhere to evolving quality standards while advancing production efficiency. In Canada, national regulatory guidance encourages alignment with international GMP standards, supporting cross-border pharmaceutical activities. Collectively, North America's regulatory assurance, healthcare demand, and corporate investment underpin its influential role in the global GMP biologics landscape.

China GMP Biologics Market- Country Insights

China has become an increasingly important player in biologics manufacturing, driven by proactive government policies and growing domestic industry capabilities. The National Medical Products Administration introduced a pilot program for segmented production of biological products in late 2024, enabling facilities to specialize in different stages of biologics manufacturing to improve efficiency and support compliance with GMP standards. Major Chinese firms such as WuXi Biologics and state-owned China National Pharmaceutical Group Corporation contribute significantly to the country's biologics output, including vaccines, antibody drugs, and complex therapeutic proteins. These developments reflect China's strategic focus on strengthening its manufacturing ecosystem, enhancing regulatory alignment, and supporting innovation to meet both domestic healthcare needs and expanding export opportunities.

GMP Biologics Market- Competitive Landscape:

Driven by the growing demand for advanced therapeutics and biologic treatments, the global GMP biologics market comprises both multinational pharmaceutical companies and regional manufacturers, making it a highly competitive sector. Companies distribute biologics through contract manufacturing, direct partnerships with healthcare providers, and specialized biopharmaceutical channels. Market participants compete on factors such as production quality, compliance with GMP standards, technological capabilities, cost efficiency, and regulatory alignment. Key strategies to strengthen market presence include expanding production capabilities, enhancing research and development initiatives, forming strategic partnerships, and pursuing targeted acquisitions. For example, WuXi Biologics and Samsung Biologics continue to strengthen global reach through advanced manufacturing facilities and strategic partnerships.

Recent Developments:

In December 2025, Samsung Biologics announced it would acquire its first U.S. drug production facility from GlaxoSmithKline for about $280 million, enabling expanded biologics production capacity in the United States and strengthening its long term manufacturing footprint.

In April 2025, WuXi Biologics completed its first commercial Process Performance Qualification (PPQ) campaign at a new 15,000L production line at its Hangzhou site. This milestone marks the successful scaling of one of Asia's largest single-use bioreactor systems, enhancing the company's commercial manufacturing capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GMP BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Samsung Biologics
  • WuXi Biologics
  • Amgen Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Merck & Co.
  • Bristol Myers Squibb
  • Sanofi
  • Lonza Group
  • Catalent Inc.
  • Thermo Fisher Scientific
  • Cobra Biologics
  • AstraZeneca plc
  • Charles River Laboratories International, Inc.
  • Rentschler Biopharma SE
  • Others

GLOBAL GMP BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Cell & Gene Therapies

GLOBAL GMP BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Immunology
  • Infectious Diseases
  • Rare Diseases
  • Cardiovascular Diseases

GLOBAL GMP BIOLOGICS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • Process Development
  • Analytical Testing Service
  • Fill-Finish Service
  • Upstream Manufacturing
  • Downstream Processing

GLOBAL GMP BIOLOGICS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Scale
  • Commercial Scale
  • Pilot Scale

GLOBAL GMP BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Research Institutes
  • Clinical Research Organizations (CROs)

GLOBAL GMP BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. GMP Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. GMP Biologics Market Snippet by Product Type
    • 2.1.2. GMP Biologics Market Snippet by Application
    • 2.1.3. GMP Biologics Market Snippet by Service
    • 2.1.4. GMP Biologics Market Snippet by Manufacturing Scale
    • 2.1.5. GMP Biologics Market Snippet by End User
    • 2.1.6. GMP Biologics Market Snippet by Country
    • 2.1.7. GMP Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. GMP Biologics Key Market Trends

  • 3.1. GMP Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. GMP Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. GMP Biologics Market Opportunities
  • 3.4. GMP Biologics Market Future Trends

4. GMP Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. GMP Biologics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. GMP Biologics Market Landscape

  • 6.1. GMP Biologics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. GMP Biologics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Monoclonal Antibodies (mAbs)
    • 7.1.3. Recombinant Proteins
    • 7.1.4. Vaccines
    • 7.1.5. Cell & Gene Therapies

8. GMP Biologics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Infectious Diseases
    • 8.1.5. Rare Diseases
    • 8.1.6. Cardiovascular Diseases

9. GMP Biologics Market - By Service

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service, 2024 & 2032 (%)
    • 9.1.2. Process Development
    • 9.1.3. Analytical Testing Services
    • 9.1.4. Fill-Finish Services
    • 9.1.5. Upstream Manufacturing
    • 9.1.6. Downstream Processing

10. GMP Biologics Market - By Manufacturing Scale

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Clinical Scale
    • 10.1.3. Commercial Scale
    • 10.1.4. Pilot Scale

11. GMP Biologics Market - By End User

  • 11.1. Overview
    • 11.1.1. Biopharmaceutical Companies
    • 11.1.2. Contract Development & Manufacturing Organizations (CDMOs)
    • 11.1.3. Research Institutes
    • 11.1.4. Clinical Research Organizations (CROs)

12. GMP Biologics Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. GMP Biologics Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. GMP Biologics Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. GMP Biologics Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. GMP Biologics Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. GMP Biologics Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- GMP Biologics Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Samsung Biologics
    • 13.2.2. WuXi Biologics
    • 13.2.3. Amgen Inc.
    • 13.2.4. Pfizer Inc.
    • 13.2.5. Roche Holding AG
    • 13.2.6. Novartis AG
    • 13.2.7. Merck & Co.
    • 13.2.8. Bristol Myers Squibb
    • 13.2.9. Sanofi
    • 13.2.10. Lonza Group
    • 13.2.11. Catalent Inc.
    • 13.2.12. Thermo Fisher Scientific
    • 13.2.13. Cobra Biologics
    • 13.2.14. AstraZeneca plc
    • 13.2.15. Charles River Laboratories International, Inc.
    • 13.2.16. Rentschler Biopharma SE
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제